Statement from EPA in relation to GlaxoSmithKline

Date released: Aug 10 2005

The EPA received notification from GlaxoSmithKline by fax and phone call to the EPA office in Cork on Friday 15 April 2005 informing us that a waste pipe-line containing aqueous waste was discovered to be connected to the wastewater treatment plant instead of being transferred for incineration.  Discharge from the waste line to the wastewater treatment facility immediately ceased and the pipes were disconnected.  

The EPA can confirm that there has been no discharge to waters of waste material and no impact to the environment.  An impact assessment on discharges from the wastewater treatment plant was required by the EPA and was received on 18 May 2005.

The assessment indicated that the aqueous waste (99% water) sent to the treatment plant had been adequately treated in the wastewater treatment plant.  This is confirmed by toxicity tests carried out by the company and EPA sampling carried out on emissions from the wastewater treatment plant during the period of the discharge.

After reviewing the impact assessment the EPA is satisfied that there was no impact to the environment. 

The EPA carried out an inspection on the 29 April 2005 to confirm that all pipe-line works had been carried out at the site.   The incorrect connection of the aqueous waste pipe-line is the subject of an on-going enforcement investigation by the EPA.

Smith kline Beecham (Manufacturing) limited / GlaxoSmithKline were granted a licence by the EPA on 9 December 1994.  This licence was revised on 20 August 1999 and is register number 473. 

In the period 2004 and 2005 a total of 12 inspections have been carried out at the facility by the EPA.